Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("ANOREXIGENE")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2368

  • Page / 95

Export

Selection :

  • and

SPECIES DIFFERENCES IN THE KINETICS AND METABOLISM OF FENFLURAMINE ISOMERSCACCIA S; BALLABIO M; GUISO G et al.1982; ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE; ISSN 0003-9780; BEL; DA. 1982; VOL. 258; NO 1; PP. 15-28; BIBL. 22 REF.Article

TRAITEMENT DE L'OBESITE AVEC LA FENFLURAMINE. EXPERIENCES CLINIQUES ET RAPPORTS BIOCHIMIQUESGUEMES DIAZ JF.1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 3; PP. 232-245Serial Issue

ETUDE EN DOUBLE INSU AVEC PERMUTATION CROISEE D'UNE SUBSTANCE ANOREXIGENE: LE CLOBENZOREXMIROUZE J; MARY P; LAPINSKI H et al.1973; J. MED. MONTPELLIER; FR.; DA. 1973; VOL. 8; NO 2; PP. 115-123 (5P.)Serial Issue

UN REEDUCATEUR DU COMPORTEMENT ALIMENTAIRE: LE CLOBENZOREX1972; REV. MED. TOULOUSE, ENSEIGN. DOCUM. INFORM.; FR.; DA. 1972; VOL. 8; NO 7; PP. 1253-1260 (5P.); BIBL. 5REF.Serial Issue

DIBOTIN (PHENFORMINE) DANS LE TRAITEMENT DE L'OBESITEMISKIEWICZ H.1972; WIADOM. LEK.; POLSKA; DA. 1972; VOL. 25; NO 21; PP. 1931-1934; ABS. RUSSE ANGL.; BIBL. 21REF.Serial Issue

STRUCTURE DETERMINATION OF THE ANOREXIC AGENT MAZINDOL = DETERMINATION DE LA STRUCTURE DE L'AGENT ANOREXIGENE MAZINDOLBARCZA S; HOULIHAN WJ.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 5; PP. 829-831; BIBL. 4 REF.Article

EFFETS DU DIETHYLPROPION, ANOREXIGENE D'ACTION PROLONGEE, CHEZ 50 OBESES. (EXPERIMENTATION A DOUBLE INSU AVEC PERMUTATION CROISEE, INTERPRETATION STATISTIQUE DES RESULTATS)MIROUZE J; MARY P; LAPINSKI H et al.1972; GAZ. MED. FR.; FR.; DA. 1972; VOL. 79; NO 26; PP. 4395-4400Serial Issue

ETUDE CLINIQUE D'UN ANOREXIGENE RECENT: LE T.D.PLAUCHU M; PAFFOY JC; PHILIPPE LP et al.1972; LYON MED.; FR.; DA. 1972; VOL. 228; NO 15; PP. 291-294Serial Issue

FENFLURAMINE: ITS USE IN OBESITYSAPEIKA N.1973; CENTR. AFR. J. MED.; RHODESIA; DA. 1973; VOL. 19; NO 2; PP. 23-24; BIBL. 16REF.Serial Issue

EFFETS ET INDICATIONS DE LA FENFLURAMINE DANS LE TRAITEMENT DE L'OBESITEVIGNATI E.1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 2; PP. 166-170; BIBL. 4REF.Serial Issue

LA FENFLURAMINE DANS LE TRAITEMENT DE L'OBESITE1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 3; PP. 243-247Serial Issue

FACTORS INFLUENCING TOLERANCE TO D-AMPHETAMINE-INDUCED ANOREXIA IN RATSMILLOY S; GLICK SD.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 221; NO 1; PP. 87-95; BIBL. 10 REF.Article

FENFLURAMINE AND 5-HYDROXYTRYPTAMINE. II. INVOLVEMENT OF BRAIN 5-HYDROXYTRYPTAMINE IN THE ANORECTIC ACTIVITY OF FENFLURAMINE. = FENFLURAMINE ET 5-HYDROXYTRYPTAMINE. II. ROLE DE LA 5-HYDROXYTRYPTAMINE CEREBRALE DANS L'ACTIVITE ANOREXIGENE DE LA FENFLURAMINEDUHAULT J; BOULANGER M; VOISIN C et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 11; PP. 1758-1762; ABS. ALLEM.; BIBL. 22 REF.Article

FENFLURAMINE IN THE TREATMENT OF OBESITYSTUNKARD A; RICKELS K; HESBACHER P et al.1973; LANCET; G.B.; DA. 1973; NO 7802; PP. 503-505; BIBL. 26REF.Serial Issue

ASPECTS EPIDEMIOLOGIQUES DE LA TOXICOMANIE AUX ANOREXIGENESVAILLE C.1979; THERAPIE; FRA; DA. 1979; VOL. 34; NO 2; PP. 221-247; ABS. ENG; BIBL. 85 REF.Article

DETERMINAZIONE DELLA CONFIGURAZIONE ASSOLUTA DI COMPOSTI AMMINICI AVENTI INTERESSE FARMACEUTICO ATTRAVERSO MISURE DI DICROISMO CIRCOLARE = DETERMINATION DE LA CONFIGURATION ABSOLUE DE DERIVES AMINES, AYANT UN INTERET PHARMACEUTIQUE, AU MOYEN DU DICHROISME CIRCULAIREBETTONI G; FRANCHINI C.1976; FARMACO, ED. SCI.; ITAL.; DA. 1976; VOL. 31; NO 2; PP. 105-111; ABS. ANGL.; BIBL. 5 REF.Article

CHLORPHENTERMINE INDUCED ULTRASTRUCTURAL ALTERATIONS IN FOETAL TISSUE = ALTERATIONS ULTRASTRUCTURALES DU TISSU FOETAL INDUITES PAR LA CHLORPHENTERMINELULLMAN RAUCH R.1973; VIRCHOWS ARCH., B; DTSCH.; DA. 1973; VOL. 12; NO 4; PP. 295-302; BIBL. 8 REF.Serial Issue

SPECIFICALLY DEUTERATED 1-PHENYLISOPROPYLAMINES. II. SYNTHESIS OF DEUTERIUM LABELLED PHENTERMINELINDEKE B; CHO AK; FEDORCHUK M et al.1972; ACTA PHARM. SUECICA; SUEDE; DA. 1972; VOL. 9; NO 6; PP. 605-608; BIBL. 6REF.Serial Issue

EFFICACITE DE LA FENFLURAMINE EN TANT QU'AUXILLIAIRE DU TRAITEMENT DIETETIQUE DE L'OBESITEBLONDHEIM SH; ROZEN P; SUPERSTINE E et al.1972; HAREFUAH; ISRAEL; DA. 1972; VOL. 83; NO 9; PP. 365-367; ABS. ANGL.; BIBL. 8REF.Serial Issue

FENFLURAMINE AND DERIVATIVES. PROCEEDINGS OF A SYMPOSIUM; MARBELLA, SPAIN; 19741975; POSTGRAD. MED. J., SUPPL.; G.B.; DA. 1975; VOL. 51; NO 1; PP. 1-189; BIBL. DISSEM.Conference Paper

TRAITEMENT DES FORTES OBESITES PAR LA FENFLURAMINE A FORTES DOSESSPROULE BC.1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 2; PP. 163-165Serial Issue

LE ROLE DES AGENTS ANOREXIQUES ET DES AUTRES MEDICAMENTS DANS LE TRAITEMENT DE L'OBESITELAURENT LPE.1972; VIE MED. CANADA FR.; CANADA; DA. 1972; VOL. 1; NO 5; PP. 491-493; BIBL. 2REF.Serial Issue

ANOREXIGENIC EFFECTS OF METOCLOPRAMIDE IN RATSALPHIN RS; BUCHHOLZ S; WARD JW et al.1972; EUROP. J. PHARMACOL.; NETHERL.; DA. 1972; VOL. 20; NO 2; PP. 241-242; BIBL. 6REF.Serial Issue

FAUT-IL PRESCRIRE DES MEDICATIONS ANOREXIGENES.SLIOSBERG R.1972; MED. INTERNE; FR.; DA. 1972; VOL. 7; NO 8-9; PP. 607-609; BIBL. 4REF.Serial Issue

WIRKUNGSWEISE UND INDIKATION DER APPETITZUEGLER IN DER THERAPIE DES UBERGEWICHTS = MODE D'ACTION ET INDICATION DES ANOREXIGENES DANS LE TRAITEMENT DE L'OBESITESTAUFFACHER W.1975; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1975; VOL. 105; NO 15; PP. 461-466; ABS. ANGL.; BIBL. 20 REF.Article

  • Page / 95